Hayes Debuts Gene Test-Evaluation Service To Help Payors Determine Validity of Tests | GenomeWeb
At a time when payors are increasingly demanding that diagnostic tests be clinically useful and valid in order to garner reimbursement, Philadelphia-based healthcare research and analysis firm Hayes has launched a service designed to help insurers, hospitals, and policymakers sift through the published data to make this determination. 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.